Background: Hip fracture repair is the most common noncardiac surgery done in elderly patients. Current perioperative guidelines suggest that risk for cardiac complications from orthopedic procedures is 1% to 5%, but these estimates are not specific to the risks associated with hip fracture repair. Findings: Of 1212 patients (mean age, 85.3 years; 76% female) having hip fracture repair in this retrospective, 1:2 case-control study from 1988 to 2002, nearly 14% (167 patients) had MI within 7 days of surgery; 92% of events occurred in the first 48 hours, and 75% were asymptomatic. Compared with patients without MI, those with MI had higher mortality in-hospital (14.4% vs. 1.2%; P Ͻ 0.001) and at 30 days (17.4% vs. 4.2%; P Ͻ 0.001) and 1 year (39.5% vs. 23%; P Ͻ 0.001).
Cautions: This was a single-center study. The diagnosis of MI varied over the periods in which measurements of creatine kinase (1988 -2000) and troponin (2000 -2002) were used. Statin use was not analyzed, and there was low use of ␤-blockers (15%) and angiotensin-converting enzyme inhibitors (25%). Implications: Elderly patients undergoing hip fracture repair have a higher incidence of perioperative MI than expected and are generally asymptomatic. These findings highlight the need for active surveillance of clinical symptoms, electrocardiographic monitoring of ST-T-wave changes, and use of cardiac troponin to improve recognition of postoperative MI in elderly patients. Background: More than 200 million adults have major noncardiac surgery worldwide each year, and at least 1 million die within 30 days of surgery. Little is known about optimal troponin levels to predict mortality in these patients. Findings: This prospective, international cohort study involving more than 15 000 patients aged 45 years or older who had noncardiac surgery had elevations in threshold troponin T (TnT) in the first 3 days after surgery that were associated with higher 30-day mortality. Compared with patients with nonelevated TnT levels whose 30-day mortality was 1.0%, hazard ratios (HRs) for death were as follows: 2.41 (95% CI, 1.33 to 3.77) with 4.0% mortality for a TnT level of 0.02 ng/mL; 5.00 (CI, 3.72 to 6.76) with 9.3% mortality for a TnT level of 0.03 to 0.29 ng/ mL; and 10.48 (CI, 6.25 to 16.62) with 16.9% mortality for a TnT level of 0.30 ng/mL or higher. Approximately three fourths of patients with an elevated TnT level had the elevation within the first 24 hours after surgery. The higher the peak TnT level, the shorter the median time to death. Adding TnT to clinical preoperative risk factors led to net improvement in reclassification of events. Cautions: These estimates apply to fourth-generation TnT assays only. Any clinical actions taken in response to elevated TnT levels that may have influenced mortality are unknown.
Troponin T Levels Independently Predict 30-Day Mortality
Implications: Peak postoperative TnT levels during the first 3 days after surgery were associated with 30-day mortality. Monitoring these levels using thresholds of 0.02, 0.03 to 0.29, and 0.30 ng/mL or higher identified at-risk subgroups and improved mortality risk stratification compared with only preoperative risk factors. Clinical trials are needed to determine whether interventions in the immediate postoperative period could reduce the risk for mortality. 3 .58 to 7.13]), but not for those who had TKR. The association was strongest in patients aged 80 years or older, and having AMI in the past 6 months increased the rate. The absolute 6-week risk was 0.51% for patients who had THR and 0.21% for patients who had TKR. Cautions: This study used data from an epidemiologic database from 1998 through 2007. The investigators did not have information on variables associated with AMI, such as smoking, blood pressure, and use of perioperative cardiac medications and anticoagulation, which varied over the 10-year study period. Implications: Rates of AMI increased for up to 6 weeks after joint replacement surgery, particularly in older patients. Providers referring patients for the procedure should offer appropriate counseling and consider ongoing risk assessment for a 2-to 6-week period after the procedure. The authors suggest that THR should be contraindicated in patients who have had AMI in the 12 months before surgery. Background: There are few empirical data to guide the management of patients receiving long-term warfarin therapy who require procedures. Findings: This cohort study sought to determine 3-month incidence of and risk factors for bleeding among 2182 consecutive patients receiving long-term warfarin therapy who were referred over an 11-year period to a thrombophilia clinic for periprocedural warfarin interruption and anticoagulation management. Of these, 1496 patients (69%) were given bridging therapy with low-molecular-weight heparin. The 3-month incidence rate for all patients was 5.1% for overall bleeding and 2.1% for major bleeding; however, major bleeding was more frequent in patients receiving periprocedural heparin (3% vs. 1%; P ϭ 0.017). Clinical variables associated with major bleeding were mitral mechanical heart valve (HR, 2. 
Risk for

Anticoagulation
Cautions:
The data came from a single, large thrombophilia center from 1997 through 2007. Patients receiving bridging heparin differed clinically from those who did not. The study did not account for total low-molecularweight heparin dose or international normalized ratio time in range. Implications: Bridging heparin therapy is associated with periprocedural bleeding, which might be reduced by delaying reinitiation of therapeutic heparin for more than 24 hours. The study investigators concluded with their management strategy: They restart warfarin after the procedure as soon as the patient can receive oral medications and wait 48 hours before resuming therapeutic bridging heparin, acknowledging that venous thromboembolism prophylaxis could be started sooner as per guidelines (1) . Finally, they reserve therapeutic heparin doses for patients at highest risk for thromboembolism. 
01]).
Cautions: This single-center study took place in an urban environment, with potential socioeconomic and communication issues. Lack of patient understanding of the risks for discharge against medical advice, lack of plans for follow-up care, and care provided by trainees with less experience may have contributed to the results. There also was no follow-up for admission to other facilities. Implications: Discharging patients against medical advice may be associated with worse outcomes attributable to premature discharge. The provider must consider the patient's right to accept or decline medical treatment and explain and document the increased risk for mortality and readmission. Patients without decision-making capacity should have surrogate decision makers who can understand the risks.
Longer Attempts at Resuscitation Associated With Survival After In-Hospital Cardiac Arrest
Goldberger ZD, Chan PS, Berg RA, et al; American Heart Associa- Background: Whether a restrictive transfusion strategy differs from a liberal strategy for patients with cardiovascular disease requiring transfusion after hip fracture surgery is unknown. Findings: Patients (mean age, 81.6 years; Ͼ75% female) with a history of or risk factors for cardiovascular disease and whose hemoglobin level was below 10 g/dL after hip fracture surgery were randomly assigned to a liberal transfusion strategy to maintain a hemoglobin level of 10 g/dL (n ϭ 1007), or to a restrictive strategy comprising transfusion for symptoms of anemia or at physician discretion for a hemoglobin level lower than 8 g/dL (n ϭ 1009). Patients assigned to the liberal strategy received more transfusions than those assigned to the restrictive strategy (median, 2 vs. 0 units transfused, respectively). No significant difference was found between patients assigned to either strategy for in-hospital acute coronary syndrome and mortality (4.3% vs. 5.2%; absolute risk difference, Ϫ0.9% [99% CI, Ϫ3.3% to 1.6%]), 60-day mortality (7.6% vs. 6.6%; absolute risk difference, 1.0% [99% CI, Ϫ1.9% to 4.0%]), or combined mortality and inability to walk across a room 
